Search results
Stroke Risk Scale Helps ID Candidates for Anticoagulation
Medscape· 6 days agoA common stroke risk calculator can help electrophysiologists and cardiologists distinguish which...
Radiopharma specialist Telix pulls last-minute plug on $232m IPO
Pharmaceutical Technology via Yahoo Finance· 6 days agoIn the latest development in the ever-changing biotech IPO landscape, Telix Pharmaceuticals has...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 2 days agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials...
Morningstar· 6 days agoFN Media Group News Commentary - According to a report from Mordor Intelligence the Acute Myeloid Leukemia Market size is estimated at USD 1.83 billion in 2024, and is expected to reach USD ...
How AI Is Revolutionizing Drug Development
New York Times· 6 days agoIn high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. Steve Lohr reported from the Terray...
Gateway - Quartz
Quartz· 5 days agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
Amicus Therapeutics opens global HQ in Princeton
NJBIZ· 2 days agoAmicus Therapeutics cut the ribbon last week on a sparkling new global headquarters located on Hulfish Street in Princeton. Founded by John Crowley in...
Here are the Best Companies to work for in NJ, according to US News and World report
App.com | Asbury Park Press via Yahoo Finance· 7 days agoInterested in a career change? You may be in luck. US News and World report just released their list of Best Companies To Work For and there are eight New Jersey based companies that earned ...
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
MedPage Today· 4 days agoHigh-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
New York Times· 2 days agoPharmacy benefit managers are driving up drug costs for millions of people, employers and the...
